Chardan Downgrades Regeneron Pharmaceuticals, Notes Valuation Concerns

By: via Benzinga
Gbola Amusa, Chardan Capital Markets' head of healthcare research, commented in a note on Monday that investors should be "more ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.